ArticlePLoS pathogens2020

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

Nicole Caduff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.